Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer.
Future Oncol. 2022 Jun;18(20):2465-2473. doi: 10.2217/fon-2022-0093. Epub 2022 May 10.
Future Oncol. 2022.
PMID: 35535555
Free article.
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Van Dao T, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgué A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Marcovitz M, Makowsky M, He P, Kurland JF, Negro A, Sangro B.
Abou-Alfa GK, et al. Among authors: marcovitz m.
NEJM Evid. 2022 Aug;1(8):EVIDoa2100070. doi: 10.1056/EVIDoa2100070. Epub 2022 Jun 6.
NEJM Evid. 2022.
PMID: 38319892
Item in Clipboard
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Mayadev J, Nunes AT, Li M, Marcovitz M, Lanasa MC, Monk BJ.
Mayadev J, et al. Among authors: marcovitz m.
Int J Gynecol Cancer. 2020 Jul;30(7):1065-1070. doi: 10.1136/ijgc-2019-001135. Epub 2020 May 23.
Int J Gynecol Cancer. 2020.
PMID: 32447296
Free PMC article.
Item in Clipboard
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.
Duke ES, Bradford D, Marcovitz M, Amatya AK, Mishra-Kalyani PS, Nguyen E, Price LSL, Fourie Zirkelbach J, Li Y, Bi Y, Kraft J, Dorff SE, Scepura B, Stephenson M, Ojofeitimi I, Nair A, Han Y, Tezak Z, Lemery SJ, Pazdur R, Larkins E, Singh H.
Duke ES, et al. Among authors: marcovitz m.
Clin Cancer Res. 2023 Sep 15;29(18):3573-3578. doi: 10.1158/1078-0432.CCR-23-0459.
Clin Cancer Res. 2023.
PMID: 37265412
Free PMC article.
Clinical Trial.
Item in Clipboard
Ca-dependent inhibitor of the Na+K ATPase extracted from human red cell membranes: distinction and independence from calmodulin.
Yingst DR, Polasek DM, Marcovitz MJ.
Yingst DR, et al. Among authors: marcovitz mj.
Prog Clin Biol Res. 1984;168:127-32.
Prog Clin Biol Res. 1984.
PMID: 6151187
No abstract available.
Item in Clipboard
Effect of hemolysate on calcium inhibition of the (Na+ + K+)-ATPase of human red blood cells.
Yingst DR, Marcovitz MJ.
Yingst DR, et al. Among authors: marcovitz mj.
Biochem Biophys Res Commun. 1983 Mar 29;111(3):970-9. doi: 10.1016/0006-291x(83)91395-5.
Biochem Biophys Res Commun. 1983.
PMID: 6301494
Item in Clipboard
Cite
Cite